Models for the directed evolution of bacterial allelopathy: Bacteriophage lysins

PeerJ

Volumn 2015, Issue 4, 2015, Pages

  Bull, James J ^a   Crandall, Cameron ^b   Rodriguez, Anna ^b   Krone, Stephen M ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF IDAHO   (United States)

Author keywords

Antibiotic; Directed evolution; Lysin

Indexed keywords

BACTERIOPHAGE LYSIN; MICROBIAL ENZYME; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; BACTERIAL ALLELOPATHY; BACTERIAL GROWTH; BACTERIAL KINETICS; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIOPHAGE; COMPUTER ANALYSIS; DIRECTED MOLECULAR EVOLUTION; EXPERIMENTAL DESIGN; GENE AMPLIFICATION; MATHEMATICAL PHENOMENA; NONHUMAN; ORGANISMAL INTERACTION; PLASMID;

BACTERIA (MICROORGANISMS);

EID: 84926436274     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.879     Document Type: Article

References (25)

1. Borysowski J, Weber-Dabrowska B, Górski A. 2006. Bacteriophage endolysins as a novel class of antibacterial agents. Experimental Biology and Medicine 231(4):366-377.
2. Chan BK, Abedon ST. 2014. Bacteriophages and their enzymes in biofilm control. Current Pharmaceutical Design 21(1):85-99 DOI 10.2174/1381612820666140905112311.
3. Chao L, Levin BR. 1981. Structured habitats and the evolution of anticompetitor toxins in bacteria. Proceedings of the National Academy of Sciences of the United States of America 78(10):6324-6328 DOI 10.1073/pnas.78.10.6324.
4. Cheng Q, Fischetti VA. 2007. Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci. Applied Microbiology and Biotechnology 74(6):1284-1291 DOI 10.1007/s00253-006-0771-1.
5. Crow JF, Kimura M. 1970. An introduction to population genetics theory. Minneapolis: Burgess Pub. Company.
6. Díez-Martínez R, de Paz HD, de Paz H, Bustamante N, García E, Menéndez M, García P. 2013. Improving the lethal effect of cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module. Antimicrobial Agents and Chemotherapy 57(11):5355-5365 DOI 10.1128/AAC.01372-13.
7. Farinas ET, Bulter T, Arnold FH. 2001. Directed enzyme evolution. Current Opinion in Biotechnology 12(6):545-551 DOI 10.1016/S0958-1669(01)00261-0.
8. Fenton M, Ross P, McAuliffe O, O'Mahony J, Coffey A. 2010. Recombinant bacteriophage lysins as antibacterials. Bioengineered Bugs 1(1):9-16 DOI 10.4161/bbug.1.1.9818.
9. Fischetti VA. 2003. Novel method to control pathogenic bacteria on human mucous membranes. Annals of the New York Academy of Sciences 987:207-214 DOI 10.1111/j.1749-6632.2003.tb06050.x.
10. Fischetti VA. 2008. Bacteriophage lysins as effective antibacterials. Current Opinion in Microbiology 11(5):393-400 DOI 10.1016/j.mib.2008.09.012.
11. Fischetti VA. 2010. Bacteriophage endolysins: a novel anti-infective to control gram-positive pathogens. International Journal of Medical Microbiology 300(6):357-362 DOI 10.1016/j.ijmm.2010.04.002.
12. Fischetti VA. 2011. Exploiting what phage have evolved to control gram-positive pathogens. Bacteriophage 1(4):188-194 DOI 10.4161/bact.1.4.17747.
13. Gallet R, Kannoly S, Wang I-N. 2011. Effects of bacteriophage traits on plaque formation. BMC Microbiology 11:181 DOI 10.1186/1471-2180-11-181.
14. Heselpoth RD, Nelson DC. 2012. A new screening method for the directed evolution of thermostable bacteriolytic enzymes. Journal of Visualized Experiments 69:e4216 DOI 10.3791/4216.
15. Loeffler JM, Nelson D, Fischetti VA. 2001. Rapid killing of streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294(5549):2170-2172 DOI 10.1126/science.1066869.
16. Loessner MJ, Kramer K, Ebel F, Scherer S. 2002. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Molecular Microbiology 44(2):335-349 DOI 10.1046/j.1365-2958.2002.02889.x.
17. LuW-C, Ellington AD. 2013. In vitro selection of proteins via emulsion compartments. Methods 60(1):75-80 DOI 10.1016/j.ymeth.2012.03.008.
18. McGowan S, Buckle AM, Mitchell MS, Hoopes JT, Gallagher DT, Heselpoth RD, Shen Y, Reboul CF, Law RHP, Fischetti VA, Whisstock JC, Nelson DC. 2012. X-ray crystal structure of the streptococcal specific phage lysin PlyC. Proceedings of the National Academy of Sciences of the United States of America 109(31):12752-12757 DOI 10.1073/pnas.1208424109.
19. Nelson D, Loomis L, Fischetti VA. 2001. Prevention and elimination of upper respiratory colonization of mice by group a streptococci by using a bacteriophage lytic enzyme. Proceedings of the National Academy of Sciences of the United States of America 98(7):4107-4112 DOI 10.1073/pnas.061038398.
20. Pastagia M, Schuch R, Fischetti VA, Huang DB. 2013. Lysins: the arrival of pathogendirected anti-infectives. Journal of Medical Microbiology 62(pt 10):1506-1516 DOI 10.1099/jmm.0.061028-0.
21. R Development Core Team. 2012. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. Available at http://www. R-project.org/.
22. Riley MA, Robinson SM, Roy CM, Dennis M, Liu V, Dorit RL. 2012. Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge. Biochemical Society Transactions 40(6):1438-1442 DOI 10.1042/BST20120179.
23. Riley MA, Wertz JE. 2002. Bacteriocins: evolution, ecology, and application. Annual Review of Microbiology 56:117-137 DOI 10.1146/annurev.micro.56.012302.161024.
24. Roychoudhury P, Shrestha N, Wiss VR, Krone SM. 2014. Fitness benefits of low infectivity in a spatially structured population of bacteriophages. Proceedings. Biological Sciences/The Royal Society 281(1774):20132563 DOI 10.1098/rspb.2013.2563.
25. Schmelcher M, Shabarova T, Eugster MR, Eichenseher F, Tchang VS, Banz M, Loessner MJ. 2010. Rapid multiplex detection and differentiation of Listeria cells by use of fluorescent phage endolysin cell wall binding domains. Applied and Environmental Microbiology 76(17):5745-5756 DOI 10.1128/AEM.00801-10.